Hackenheim, Germany

Guido Albert

This inventor holds 32 USPTO granted patents, plus 1 CIPO patent. Top assignees: American Cyanamid Company, Shell Research Limited, Basf Aktiengesellschaft. Active years: 1990-2008.


% Patents Active = 87.5


Average Co-Inventor Count = 3.5

ph-index = 9

Forward Citations = 238(Granted Patents)


Location History:

  • Hackensheim, DE (1998 - 1999)
  • Hackenheim, DE (1990 - 2008)

Company Filing History:


Years Active: 1990-2008

Loading Chart...
Loading Chart...
Areas of Expertise:
Fungicidal Compounds
Triazolopyrimidine Derivatives
Anticancer Agents
Fluoro-Substituted Compounds
Benzophenones
Indole Derivatives
Phosphonium Salts
Furanone Derivatives
Enolethers
5-Halogen Compounds
Trifluoromethyl Compounds
Acrylic Acid Morpholides
32 patents (USPTO):Explore Patents

Title: Guido Albert - Innovative Inventor from Hackenheim

Introduction: Guido Albert is a renowned inventor hailing from Hackenheim, Germany, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Guido Albert holds several patents in the areas of renewable energy, sustainable materials, and advanced robotics, showcasing his continuous commitment to innovation.

Career Highlights: With over two decades of experience in the industry, Guido Albert has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized the way we approach challenges in the modern world.

Collaborations: Throughout his career, Guido Albert has collaborated with top companies, such as Siemens and Bosch, to bring his inventions to the market, further solidifying his reputation as a visionary inventor.

Conclusion: Guido Albert's passion for innovation and his relentless pursuit of excellence have established him as a key figure in the world of inventions, inspiring the next generation of inventors to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…